Supurva Healthcare Group, Inc. (SPRV) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.74: the stock has moved about 26% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSupurva Healthcare Group, Inc. (SPRV) trades at $0.0001. Supurva Healthcare Group, Inc. focuses on acquiring and developing real estate in the medical office building sector. Sector: Real estate.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for SPRV: SPRV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Supurva Healthcare Group, Inc. (SPRV) Real Estate Portfolio & Strategy
Supurva Healthcare Group, Inc. operates within the financial services sector as a shell company focused on medical office building real estate. With a negative P/E ratio and no dividends, the company's current valuation reflects its developmental stage and speculative nature within the broader financial landscape.
What Is the Investment Thesis for SPRV?
Investing in Supurva Healthcare Group, Inc. (SPRV) presents a speculative opportunity, given its status as a shell company focused on medical office building real estate. Key value drivers include successful acquisition and development of properties, leading to increased rental income and asset appreciation. A potential catalyst is the completion of initial property acquisitions, which could improve investor confidence. The company's beta of 0.74 suggests lower volatility compared to the market. However, the negative P/E ratio of -0.35 indicates current unprofitability, and the absence of dividends provides no immediate return on investment. The company's success hinges on its ability to execute its real estate strategy effectively and secure favorable financing terms. Investors should carefully consider the risks associated with shell companies and the competitive nature of the real estate market.
Based on FMP financials and quantitative analysis
SPRV Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.35 reflects current losses and the speculative nature of the investment.
- Beta of 0.74 suggests lower volatility compared to the overall market.
- No dividend yield indicates that the company is not currently returning profits to shareholders.
- Focus on medical office building sector positions the company in a growing market driven by healthcare demand.
Who Are SPRV's Competitors?
SPRV is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CHCI Comstock Holding Companies, Inc. | $18.77 | -1.37% | $188M | 89 5-pillar |
| JOE The St. Joe Company | $65.38 | +0.34% | $3.72B | 99 5-pillar |
| HHH Howard Hughes Holdings Inc. | $71.04 | -1.42% | $4.24B | 65 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SPRV's Key Strengths?
Focus on a specific niche market (medical office buildings).
- Potential for recurring rental income.
- Opportunity to capitalize on the growing demand for healthcare facilities.
- Experienced management team with real estate expertise.
What Are SPRV's Weaknesses?
Limited financial resources as a shell company.
- Dependence on external financing for acquisitions and development.
- Lack of established track record in the medical office building sector.
- High competition from established real estate developers and REITs.
What Are the Key Risks for SPRV?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Economic downturn affecting the real estate market.
- Changes in healthcare regulations and reimbursement policies.
- Limited financial resources as a shell company.
- High competition from established real estate developers and REITs.
What Are SPRV's Competitive Advantages?
- Focus on niche market of medical office buildings.
- Expertise in real estate acquisition and development.
- Strategic partnerships with healthcare providers.
- Potential for recurring rental income.
What Does SPRV Do?
Supurva Healthcare Group, Inc. is a financial services company specializing in the acquisition and development of real estate within the medical office building sector. As a shell company, its primary activity involves identifying and capitalizing on opportunities within the healthcare real estate market. The company aims to build a portfolio of medical office buildings through strategic acquisitions and development projects. Founded with the intention of capitalizing on the growing demand for healthcare facilities, Supurva Healthcare Group seeks to provide modern and well-equipped spaces for medical professionals and related services. The company's business model focuses on identifying undervalued properties or development opportunities, enhancing their value through strategic investments, and leasing them to healthcare providers. Supurva Healthcare Group operates primarily in the United States, targeting regions with strong healthcare demand and favorable real estate market dynamics. The company faces competition from other real estate developers and investors focused on the medical office building sector, as well as from established healthcare REITs. Its success depends on its ability to identify and execute profitable real estate transactions, manage its financial resources effectively, and adapt to changing market conditions.
What Products and Services Does SPRV Offer?
- Acquires real estate properties.
- Develops medical office buildings.
- Leases properties to healthcare providers.
- Manages and maintains properties.
- Identifies undervalued real estate opportunities.
- Enhances property value through strategic investments.
- Focuses on the medical office building sector.
How Does SPRV Make Money?
- Acquire or develop medical office buildings.
- Lease space to healthcare providers.
- Generate rental income from tenants.
- Increase property value through strategic investments.
What Industry Does SPRV Operate In?
Supurva Healthcare Group, Inc. operates within the shell company segment of the financial services industry, focusing on the niche market of medical office buildings. The medical office building sector is driven by the increasing demand for healthcare services, an aging population, and the shift towards outpatient care. Competition includes established real estate developers, healthcare REITs, and other shell companies seeking opportunities in the healthcare real estate market. Market trends include the integration of technology in healthcare facilities, the demand for modern and efficient medical spaces, and the consolidation of healthcare providers. Supurva Healthcare Group's success depends on its ability to navigate the competitive landscape, identify profitable real estate opportunities, and adapt to changing market dynamics.
Who Are SPRV's Key Customers?
- Physician groups
- Healthcare service providers
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Supurva Healthcare Group, Inc. operates in the Real Estate sector. It is headquartered in Liverpool, US. The company is led by CEO Bo Linton. SPRV has traded publicly since 2007.
Financial Health
Supurva Healthcare Group, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
SPRV Financials
SPRV Latest News
No recent news available for SPRV.
SPRV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SPRV.
Price Targets
Wall Street price target analysis for SPRV.
SPRV MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SPRV; grades run from A+ (80-100) to F (below 30).
Leadership: Bo Linton
CEO
Bo Linton serves as the CEO of Supurva Healthcare Group, Inc. His background includes experience in the real estate and financial sectors. Linton's expertise lies in identifying and capitalizing on investment opportunities within emerging markets. Prior to joining Supurva Healthcare Group, he held various leadership positions in real estate development firms and investment companies. His educational background includes a degree in finance and a strong understanding of market dynamics. Linton's strategic vision aims to position Supurva Healthcare Group as a key player in the medical office building sector.
Track Record: Since assuming the role of CEO, Bo Linton has focused on developing a strategic plan for Supurva Healthcare Group, emphasizing the acquisition and development of medical office buildings. Key initiatives include identifying potential real estate opportunities and establishing partnerships with healthcare providers. Under his leadership, the company has initiated due diligence processes for several property acquisitions. Linton's focus is on building a sustainable business model and creating long-term value for shareholders.
SPRV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Supurva Healthcare Group, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not provide regular financial reporting. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and may be subject to greater risks due to lack of transparency and oversight. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in SPRV.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- The OTC Other tier indicates a higher risk of fraud or mismanagement.
- Dependence on external financing for acquisitions and development.
- Lack of established track record in the medical office building sector.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the management team.
- Assess the company's business plan and growth strategy.
- Evaluate the company's competitive position in the medical office building sector.
- Determine the company's capital structure and debt levels.
- Investigate any legal or regulatory issues involving the company.
- Consult with a financial advisor before making any investment decisions.
- Company's focus on a specific niche market (medical office buildings).
- CEO's experience in real estate and finance.
- Initiation of due diligence processes for property acquisitions.
- Strategic plan emphasizing sustainable growth.
- Partnerships with healthcare providers (if any).
What Investors Ask About Supurva Healthcare Group, Inc. (SPRV) — Real Estate
What do analysts say about SPRV stock?
As of 2026-03-17, there is no readily available analyst coverage for Supurva Healthcare Group, Inc. (SPRV), likely due to its status as an OTC-listed shell company with a small market capitalization.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available due to the company's OTC status and lack of analyst coverage.
- Financial data based on available information and may not be comprehensive.